Back to Journals » Cancer Management and Research » Volume 14

Exosome-Encapsulated MicroRNA-21 from Esophageal Squamous Cell Carcinoma Cells Enhances Angiogenesis of Human Umbilical Venous Endothelial Cells by Targeting SPRY1 [Retraction]

Authors Zhuang H, Wang H, Yang H, Li H

Received 4 February 2022

Accepted for publication 4 February 2022

Published 9 February 2022 Volume 2022:14 Pages 499—500

DOI https://doi.org/10.2147/CMAR.S361148



Zhuang H, Wang H, Yang H, Li H. Cancer Manag Res. 2020;12:10651—10667.

At the authors request, the Editor and Publisher of Cancer Management and Research wish to retract the published article. The authors have informed the journal that they have concerns with the reliability of the published results and they cannot provide any original data relating to their study and can no longer verify the findings as reported. In addition, the authors have advised they did not obtain ethics approval from the Ethics Committee of Linyi People’s Hospital to conduct the animal experiments and the Hongjun Wang and Haibo Yang were added as authors without their knowledge or approval. The authors wish to apologize for this.

The Editor has agreed with the request to retract the article.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.